Abstract
Severe adverse systemic and ocular reactions have complicated the chemotherapy of onchocerciasis. A method for the quantification of ocular reactions to chemotherapy has been devised at the Onchocerciasis Chemotherapy Research Centre, at Hohoe, in Ghana. Symptoms, visual function, anterior segment inflammation and disease of the posterior segment are graded. The information is entered into a computerised database which allows reaction scores to be calculated both for individual patients, and for treatment groups. This system enables comparision of adverse ocular reactions to various new chemotherapeutic regimens.
Similar content being viewed by others
Article PDF
References
Bryceson ADM, Warrell DA, Pope HM : Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine. Br Med Journal 1977, 1: 742–44.
Awadzi K and Gilles HM : The chemotherapy of onchocerciasis III: A comparative study of diethylcarbamazine (DEC) and metrifonate. Ann Trap Med Parasirol 1980, 74: 199–210.
Greene BM, Taylor HR, Brown EJ et al.: Ocular and systemic complications of diethylcarbamazine therapy on onchocerciasis. Association with circulating immune complexes. J Infect Dis 1983, 147: 890–7.
Anderson J and Fuglsang H : Effects of diethylcarbamazine on ocular onchocerciasis. Tropenmed Parasitol 1976, 27: 263–78.
Bird AC, EI-Sheikh H, Anderson J, Fuglsang H : Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. Br J Ophthalmol 1980, 64: 191–200.
Taylor HR, Greene BM : Ocular changes with oral and trans-epidermal diethylcarbamazine therapy of onchocerciasis. Br J Ophthalmol 1981, 65: 494–502.
Awadzi K : The chemotherapy of onchocerciasis II. Quantitation of the clinical reaction to microfilaricides. Ann Trop Med Parasitol 1980. 74: 190–7.
Greene BM, Taylor HR, Cupp EW et al.: Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 1985, 313: 133–8.
De Sole G, Remme J, Awadzi K et al.: Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull of the World Health Org 1989, 67: 707–19.
Keyvan Larijani E, Newland HS, Taylor HR : An ocular reaction index for use in the study of onchocerciasis. Tropenmed Parasitol 1985, 36: 241–3.
Bird AC, Anderson J, Fuglsang H : Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol 1976, 60: 2–20.
Dadzie KY, Bird AC, Awadzi K, Schultz-Key H, Gilles HM, Aziz MA : Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. Br J Ophthalmol 1987, 71: 78–85.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herot, M., Bird, A. & Awadzi, K. Quantification of the ocular reactions to microfilaricides in the chemotherapy of onchocerciasis. Eye 6, 93–96 (1992). https://doi.org/10.1038/eye.1992.19
Issue Date:
DOI: https://doi.org/10.1038/eye.1992.19
Keywords
This article is cited by
-
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia
Parasites & Vectors (2024)
-
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch
Parasites & Vectors (2015)